Navigation Links
Imagenetix Enters into Business Relationship with MonaVie

SAN DIEGO, June 2 /PRNewswire-FirstCall/ -- Imagenetix, Inc. (OTC Bulletin Board: IAGX) announced today that it has entered into a business relationship with MonaVie LLC ( that provides for Celadrin(R) to be utilized in MonaVie Active.

Celadrin, a cellular lubricant, is a joint health breakthrough that provides fast, long lasting joint comfort. Providing continuous lubrication, Celadrin improves cell membrane fluidity and elasticity. Celadrin is a unique, scientifically arranged matrix of all natural, esterified oil. Further, Celadrin has been subjected to over 17 scientific studies at leading universities and pharmaceutical laboratories throughout the world, with the results published in medical journals.

"We are extremely excited about the future of MonaVie as it relates to our relationship with Imagenetix," said Dallin Larsen, of MonaVie. "Celadrin is a reputable and proven product that fits well with MonaVie's mission to provide our consumers with products that promote healthy, active lifestyles."

"Imagenetix has the utmost confidence in MonaVie and its executive team, and are proud to be their associates," said Bill Spencer, of Imagenetix. "Considering what both companies bring to the table in terms of product quality and industry experience, this business partnership just makes sense. Based on this relationship we expect MonaVie to become one of our largest customers."

About MonaVie

MonaVie LLC is a rapidly growing company that distributes products to markets around the world. Introduced in January 2005, MonaVie develops and markets scientifically formulated, premium quality products, specifically for person-to-person distribution. Developed with a philosophy of Balance-Variety-Moderation, MonaVie brand products deliver phytonutrients and antioxidants to promote and maintain a healthy and active lifestyle. For more information about MonaVie brand products or how to join the MonaVie family, call 1-866-217-8455, or visit

About Imagenetix

Based in San Diego, California, Imagenetix, (OTCBB: IAGX) is an innovator of scientifically tested, natural-based, proprietary, bioceutical products developed to enhance human health on a global basis. Imagenetix develops and formulates private-labels, propriety over-the-counter topical creams, skincare products and nutritional supplements to be marketed globally through multiple channels of distribution. In addition, the company develops patentable compounds for entering into licensing agreements with pharmaceutical partners. Imagenetix is the creator of Inflame Away(R)-Celadrin(R), which has been clinically tested to relieve osteoarthritis pain and significantly improve joint health. For more information on Celadrin(R), please visit, or

SOURCE Imagenetix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Kroger and The Little Clinic Establish Partnership to Offer Customers Convenient Healthcare Centers Inside Their Neighborhood Store
2. Fitworks Fitness Centers Responds to the Growing Adolescent Obesity Rate by Offering Free Summer Memberships to Teens 13-15 Years of Age
3. China Pharma Holdings, Inc. Enters Into Private Placement Agreements to Raise $10 Million
4. Seahorse Bioscience Enters into Agreement with Primetech Corporation to Bring XF Technology to Japanese Market
5. Phyhealth Enters Agreement with Merrill Lynch to Manage Capital Surplus Funds for Phyhealth Pilot HMO
6. Widespread airbag use could result in dramatic cost savings for US trauma centers
7. Partnership of academic centers and community hospitals effective model for disseminating advances
8. Cancer Centers of North Carolina Receives Prestigious Accreditation
9. General Nutrition Centers, Inc. Reports First Quarter 2008 Financial Results
10. Centers for Medicare & Medicaid Services Awards Ogilvy Public Relations Worldwide $1.4 Million Dollar Contract
11. Flip Flops, Mulch and No Coat: Study Identifies Surprising Barriers to Outdoor Activity for Kids in Child-Care Centers
Post Your Comments:
(Date:11/27/2015)... Los Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... new study carried out by the University of Toronto and the University of British ... number of hospitalizations for head injuries. The article explains that part of the reason ...
(Date:11/27/2015)... ... November 27, 2015 , ... An ... way to dispense prescription medications at home, so he invented the patent-pending ELECTRONIC ... and dispense prescription medications. In doing so, it could help to prevent potential ...
(Date:11/27/2015)... ... November 27, 2015 , ... ProSidebar: Fashion is a set ... With ProSidebar: Fasion, video editors can easily add an informative sidebar to any ... opener. Utilize presets featuring self-animating drop zones, lines, bars, and text with the ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television series, "Voices in America", ... delves into an array of issues that are presently affecting Americans. Dedicated to providing ... this show is changing the subjects consumers focus on, one episode at a time. ...
(Date:11/27/2015)... ... November 27, 2015 , ... The men and ... nonprofit healthcare organizations in the country. They have overseen financial turnarounds, shown commitment ... advance the healthcare industry as a whole through their advocacy and professional efforts. ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... -- ) has announced the ... Viscosity Drugs" report to their offering. ... of the "Self Administration of High Viscosity ... Research and Markets ( ) has ... of High Viscosity Drugs" report to their ...
(Date:11/26/2015)... ) has ... Market by Type (Reagents & Kits, Analyzers), ... Diagnostic Labs), Application (Research, Clinical Diagnostics), and ... report to their offering. --> ... the "Radioimmunoassay Market by Type (Reagents ...
(Date:11/25/2015)... , Nov. 25, 2015 ... addition of the "Global Brain Monitoring ... offering. --> ) has ... Brain Monitoring Devices Market 2015-2019" report ... and Markets ( ) has announced ...
Breaking Medicine Technology: